Podcast: Play in new window
Guest:
Dr. Mingxia Gu is an Assistant Professor of Pediatrics at Cincinnati Children’s Hospital. Her lab’s goal is to develop novel therapies for the regeneration of the heart, lung, and vasculature in patients with congenital cardiac and pulmonary defects. She talks about developing lung organoids to study COVID-19, how multi-lineage organoids can mimic human tissues, and her lab’s motto to “move fast and break things.”
Featured Products and Resources:
- Grow functional airway organoids with PneumaCult™.
- Derive, expand, and differentiate human skeletal muscle progenitors with MyoCult™.
The Stem Cell Science Round Up
Mitochondrial Inheritance and Cell Fate – Metabolic bias induced by asymmetric apportioning of aged mitochondria leads to changes in cell fate and stemness.
Whole Genome Sequencing of hESCs – Researchers performed whole genome sequencing on 143 readily-available hESCs, and found that a third of them shared sibling relationships.
Single Cell Sequencing with Fewer Cells – Scientists developed a new single cell analysis platform designed for low cell-input samples.
Cardiac Wound Healing – Muscleblind-like protein 1 regulates myocardial infarction-induced cardiac fibroblast proliferation.
Photo Reference: Courtesy of Dr. Mingxia Gu
